Objectives: IncF plasmids are frequently encountered in clinical enterobacterial strains associated with the dissemination of relevant antimicrobial resistance and virulence genes. These plasmids are usually heterogeneous in size and carry multiple replicons, and technical difficulties can impair the comparison and detection of related plasmids by restriction fragment length polymorphism analysis. We devised a rapid sequence-based typing scheme to categorize the members of this plasmid family into homogeneous groups.
Introduction
IncF plasmids contribute to the fitness of the bacterial host by providing virulence and antimicrobial resistance determinants. 1 In particular, Salmonella enterica, Shigella spp. and enterohaemorrhagic Escherichia coli (EHEC), enteropathogenic E. coli (EPEC) and enteroinvasive E. coli (EIEC) are characterized by specific virulence traits, such as bacteriocins, siderophores, cytotoxins and adhesion factors, that are encoded by IncF plasmids, designated in these species as virulence plasmids. 1 The IncF plasmids have been associated with the abrupt worldwide emergence of clinically relevant extended-spectrum b-lactamases (ESBLs), such as CTX-M-15, 2 -7 but also with the spread of plasmid-mediated AmpC genes (bla CMY and bla DHA ) and quinolone and aminoglycoside resistances encoded by the genes aac(6 ′ )-Ib-cr, qnr, qepA, armA and rmtB. 8 -12 The IncF family contains a varied assortment of plasmids, whose relatedness and nomenclature are often complex. IncF plasmids are limited by host range to the family Enterobacteriaceae and rely on both self-encoded and host-encoded factors for duplication. IncF plasmids need DNA gyrase, DnaB, DnaC, DnaG, single strand binding and DNA polymerase III proteins for their replication. 13 IncF plasmids are usually low copy number plasmids, .100 kb in size, and often carry more than one replicon promoting the initiation of replication. The multi-replicon status has been described to be one means by which plasmids with a narrow host range can accomplish broad host range replication. For instance, plasmid pGSH500 from a clinical isolate of Klebsiella pneumoniae has a moderately broad host range and contains two functional replicons, one being related to the narrow host range IncFII plasmids and the second to the broad host range IncN plasmids.
14 A plasmid might occasionally be replaced or driven away by incoming plasmids carrying an incompatible replicon. Thus, the multi-replicon status can allow the acquisition of plasmids carrying incompatible replicons when replication is driven by a compatible one. The replicon that is not responsible for the control of replication can undergo a succession of genetic alterations. 15 The classic multi-replicon IncF plasmid contains the FII replicon (also designated as FIIA) regulated by CopA, a constitutively synthesized 90 nt antisense-RNA, which is normally silent, 13 and FIA and FIB replicons, which function only in enteric bacteria and are regulated by iterons, in cis-negative binding sites of the replication protein RepA. 16 In plasmids F and p307, the FII replicon is substituted by a non-functional FIC replicon. 16 By contrast, plasmids R1 and R100 of E. coli contain only one functional FII replicon, which was one of the best-studied examples of replication control by inhibition of leader peptide translation in the early 1990s. 17, 18 It has been demonstrated that FII replicons are free to diverge when associated with FIA and/or FIB replicons since they do not participate in the initiation of replication of the plasmid, generating new compatible variants that can be used to overcome the incompatibility barrier with incoming IncF plasmids. A few mismatches in the kissing loop of the antisense RNA are sufficient to eliminate the incompatibility effect among two closely related FII replicons. 14 In summary, the IncF plasmids possess great versatility of intracellular adaptation by the rapid evolution of the regulatory sequences of the replicons. These characteristics have been a factor in the great success of IncF plasmids in enteric bacteria. IncF plasmids are widely diffused in clinically relevant Enterobacteriaceae, representing one of the most frequently encountered plasmid types. For instance, the FII replicon was detected in .50% of E. coli from faeces of healthy, antibiotic-free humans and faecal flora from healthy birds in the USA. 19 Addiction systems encoded by these plasmids also contributed to the promotion of plasmid spread and adaptation to the host. IncF plasmids carrying virulenceand resistance-linked determinants can be positively selected by antimicrobials, thus implementing their adaptive strategies. 20 The mosaic structure of these plasmids impairs the application of a classical multilocus sequence typing-based approach. Most parts of the plasmid scaffold are not present in all IncF plasmids or are acquired and lost as a consequence of the fusion of the different replicons in the multi-replicon status. For instance, the genes controlling the partitioning of plasmids in daughter cells are not present in all IncF scaffolds, and addiction systems are physically linked to particular replicons (the pemI/ pemK genes are linked to the FII replicon, while vagC-vagG genes are linked to the FIA replicon). 21 In this study, we analysed the FII, FIA, FIB and FIC replicon sequences available at GenBank, proposing an IncF replicon sequence typing (RST) scheme with the aim of classifying all members of the large IncF family by a replicon sequence-based approach. This scheme was based on the in silico analysis of 90 IncF plasmids of various origins and sources available at GenBank. This scheme may provide a novel IncF plasmid nomenclature, based on replicon sequence types and assortment. The typing scheme was experimentally tested on 36 IncF virulence and resistance plasmids obtained from our collections of enteric bacteria isolated in six countries.
Materials and methods

Comparative analysis of the IncF replicons
An in silico comparative analysis of IncF replicons was performed at GenBank using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi), using as template the replication region of the FII, FIA and FIB replicons located between the primer pairs described in the PCR-based replicon typing (PBRT) method. 22 Additional iterative BLAST searches using the phylogenetically most distant family members were carried out in order to cover a maximum sequence space without corruption. For each FII, FIA and FIB family, we calculated a phylogenetic tree by neighbour-joining (NJ) analysis, tested with bootstrap values (500 replicates), using the CLC Free Workbench 4 program. Plasmids analysed in silico, their virulence and resistance characteristics and GenBank accession numbers are reported in Table 1 .
Multiple sequence alignments of the FII, FIA, FIB, FIC, FII K , FII Y and FII S alleles were performed using DNAMAN software (Lynnon BioSoft, Vaudreuil, Quebec, Canada) set for Quick Alignment with a gap penalty of 7, K-tuple of 3, number of top diagonals of 5, and a window size of 5.
Plasmids
A collection of 36 strains of E. coli, S. enterica, K. pneumoniae, Yersinia pestis and Yersinia pseudotuberculosis isolated in the UK, Italy, Spain, Albania, Algeria and Iran has been studied previously. 22 -28 Plasmids were assigned to the IncF group by PBRT. 22 Twenty IncF plasmids carried one or more of the bla CTX-M-9 , bla CTX-M-15 , bla SHV-12 , bla CMY-2 , bla TEM-1 and bla OXA-1 b-lactamase genes and the remaining plasmids did not contain any b-lactam resistance gene ( 
IncF RST
Template DNAs for replicon amplification were prepared by generating total DNA of higher purity by the Wizard Genomic DNA Purification System (Promega, Madison, WI, USA), starting from 2 mL of LuriaBertani broth cultures containing a suitable concentration of antibiotic for selection. A total of 200-400 ng of DNA per amplification reaction was used as template. All PCR amplifications were performed using the primers shown in Table 3 with the following amplification scheme (except for the primer pairs FII FW-FII RV and RepAFII FW-RepAFII RV; see below): 1 cycle of denaturation at 948C for 5 min, followed by 30 cycles of denaturation at 948C for 1 min, annealing at 608C for 30 s and elongation at 728C for 1 min; amplification was concluded with an extension programme of 1 cycle at 728C for 5 min. For primers FII FW-FII RV the same amplification scheme was used except that annealing was performed at 548C instead of 608C.
Amplicons were purified using the Wizard PCR Preps DNA Purification System (Promega) and sequenced using fluorescent dye-labelled dideoxy nucleotides with an ABI 3730 automatic DNA sequencer (Perkin-Elmer, Foster City, CA, USA). Alleles were assigned by submitting the amplicon sequence to the web site www.pubmlst.org/plasmid/. Novel IncF replicon alleles identified in this study were released under accession numbers HM751874 (B21), HM751875 (F32), HM751876 (A4), HM751877 (F31), HM751878 (B20), HM751880 (K5) and HM751881 (B22) ( Figure S1 , available as Supplementary data at JAC Online).
Characterization of the repA gene in pZM3 and IncF/97 plasmids
The repA genes of the pZM3 and IncF/97 plasmids were amplified using RepAFII FW -RepAFII RV (Table 3) , yielding amplicons of 5700 and 1700 bp, respectively, with the following amplification scheme: 1 cycle of denaturation at 948C for 5 min, followed by 30 cycles of denaturation at 948C for 1 min, annealing at 608C for 30 s and elongation at 728C for 5 min; amplification was concluded with an extension program of 1 cycle at 728C for 5 min. The amplicons were cloned in pCR2.1 cloning vector (Invitrogen, Milan, Italy) and sequenced using universal primers and primer walking, by fluorescent dye-labelled dideoxy-nucleotides with an Typing of IncF plasmids MDR, multidrug resistance (MDR indicates the presence of genes conferring resistance to aminoglycosides, sulphonamides, tetracyclines, trimethoprim and b-lactams); the presence of genes encoding ESBLs, carbapenemases, macrolide ABC efflux systems and plasmid-mediated quinolone resistance is indicated in the respective lines; T2SS, type II secretion system; T3SS, type III secretion system; CS fimbriae, clusters encoding pili of the CS1 and CS3 types; iron acquistion systems include iutA, iucABCD (encoding the aerobactin siderophore system), sitABCD (ABC iron transport system), iroBCDEN (salmochelin siderophore system) and eitABCD (putative iron transport system) clusters except when specifically indicated; AAF, aggregative adherent fimbriae; LT, heat-labile enterotoxin; STIa, heat-stable enterotoxin; LEE, locus for enterocyte effacement; APEC, avian pathogenic E. coli; NTEC, necrotoxigenic E. coli. a This plasmid shows mismatches with respect to the FII RV primer sequence. b FIA replicon interrupted by the insertion of IS629.
ABI 3730 automatic DNA sequencer (Perkin-Elmer). The regions containing the copA gene in the pZM3 and IncF/97 plasmids were obtained by PCR amplification using the FII FW-F D RV primer pair (Table 3) , generating amplicons of 600 and 1440 bp, respectively, which were fully sequenced.
Results and discussion
In silico analysis of IncF replicons
An in silico analysis comparison was performed by BlastN on DNA sequences available at GenBank for: (i) the copA region of the FII replicon; (ii) the region comprising the iterons and the replication protein repE gene of the FIA replicon; and (iii) the replication protein repB gene of the FIB replicon. These regions corresponded to the sequences targeted by the PBRT method proposed by Carattoli et al. 22 in 2005, were enclosed within the probes used by the hybridization-based replicon typing method proposed by Couturier et al. 29 in 1988 and were part of the incompatibility determinants used in the conjugation-based phenotypic classification of plasmids, defined by Datta and Hedges 30 in 1971. Therefore, these regions are the targets currently used for the identification of the IncF plasmids. The comparative analysis of DNA sequences of 90 IncF plasmids of various origins and sources available at GenBank demonstrated the existence of several alleles for each FII, FIA, FIB and FIC replicon. Multiple alignments of selected replicon sequences, representative of the various alleles identified in GenBank, produced the phylogenetic trees that are shown in Figures 1 and  2 . The largest branch obtained in the phylogenetic tree of the FII and FIC replicons showed a nucleotide identity of .90%, including all the replicons previously assigned by conjugation to the IncFII, IncFIII, IncFIV, IncFV and IncFVI groups, but also the FII replicons from the virulence plasmids of Shigella flexneri and Shigella sonnei (here designated as FII Sh ). Separate branches (nucleotide identities ,80%) were generated by FII replicons identified in Salmonella spp. (here designated as FII S ), Y. pestis, Y. pseudotuberculosis and Yersinia enterocolitica (here designated as FII Y ) and K. pneumoniae (here designated as FII K ) virulence plasmids ( Figure 1) .
The FIA and FIB replicons demonstrated lower sequence variability than the FII replicons, with the exception of some FIB replicons, here designated as Salmonella FIB, which were exclusively associated with the Salmonella virulence plasmids (Figure 2) .
The observation that FII replicons are more divergent than FIA and FIB replicons can be explained by assuming that, in the multireplicon status, the FII replicons are more free to diverge, evolving towards the establishment of novel incompatibility groups. 17, 18 Update of the PBRT scheme Several newly described IncF plasmids, including the Shigella, Salmonella, Yersinia and Klebsiella virulence plasmids, showed mismatches with the previously described PBRT primer pairs, and therefore some of these IncF plasmids may be non-typeable by the former scheme. To increase the sensitivity of the PBRT to all the members of this plasmid family, new primers were devised for detecting the FII (FII FW and FII RV), FIB (a new forward primer, FIB FW, was devised), Salmonella FIB (a new forward primer, FIB S FW, was devised), Salmonella FII (FII S FW and FII S RV), Yersinia FII (FII Y FW and FII Y RV) and Klebsiella FII (FII K FW and FII K RV) replicons (Table 3 ). The previously described FIA and FIC primer pairs were well conserved with respect to GenBank entries and were used in this study without modification with respect to the former PBRT scheme (Table 3) .
IncF RST
The DNA sequences of the replicons included among the nucleotide positions of the primers listed in Table 3 were used to set up the RST scheme for IncF plasmids (www.pubmlst.org/plasmid/). The sequence variants identified in GenBank for each respective replicon were assigned to an allele number. Thirty different alleles (named F1 to F30) were identified for the FII replicon in the sequence corresponding to the copA gene; 3 (A1-A3) and 20 (B1-B19 and B23) alleles were assigned for the FIA and FIB replicons, respectively ( Figure S1 ). Only two alleles (C1 and C2) were identified for the FIC replicon. Four (S1 -S4), four (K1-K4) and three (Y1 -Y3) alleles were identified for the FII replicons of Salmonella, Klebsiella and Yersinia plasmids, respectively ( Figure S1) .
Because of the multi-replicon nature of these plasmids, each plasmid can be identified using the FAB (FII, FIA, FIB) Used in a pair with FIB RV. c Used in a pair with FII FW for the identification of an intact FII replicon in plasmids showing a second deleted FII replicon. d These primers were used for the amplification of the entire repA gene of the FII replicon of the IncFIme plasmids, interrupted by the insertion of IS elements. In these cases the size of the amplicon can vary. They can be used for further characterization of plasmids carrying the FII replicon.
Villa et al. formula by the allele type and number identified for each replicon (like a serotype formula). For instance, the formula F1:A1:B1 was assigned to plasmid pRSB107 (AJ851089)-the first fully sequenced multi-replicon IncF plasmid-showing the allele F1 for the FII replicon, A1 for the FIA replicon and B1 for the FIB replicon, respectively. The formula F2:A2:B2 was assigned to plasmid R100 (AP000342), the prototypic reference IncF plasmid carrying only the FII replicon, which was assigned to allele F2. The A2 and B2 symbols indicate the absence of the FIA and FIB replicons, respectively. Alleles were determined and deposited at the www.pubmlst.org/ plasmid/ web site for all the IncF plasmids available to date at GenBank and representative plasmids and their respective FAB formulae are reported in Table 1 .
Atypical IncF plasmids were found in GenBank; the pIP1206 (AM886293) and pSD1_197 (CP000035) plasmids showed two copies of the FII replicon, one truncated and one functional. In these cases the allele assignation was determined only for the functional FII replicon. On the basis of the pIP1206 DNA sequences, the F D RV primer was devised and used with the FII FW primer (Table 3) to amplify the intact FII replicon. The pAA plasmid (FN554767) contained two identical copies of the FII replicons and therefore the allele assignation was univocal in this case (Table 1) .
Characterization by RST of resistance and virulence IncF plasmids
A collection of 36 IncF plasmids from E. coli, S. enterica, Y. pestis, Y. pseudotuberculosis and K. pneumoniae strains were typed by RST ( Table 2 ). The replicons from these plasmids were amplified using the primers shown in Table 3 and the DNA sequences of the alleles were determined. All were positive for the FII replicon, 21 also carried FIB and 12 also carried FIA replicons. Ten plasmids showed a multi-replicon status with the three FII, FIA and FIB replicons.
From this plasmid collection, the new alleles F31, F32, A4, B20, B21, B22 and K5 were identified ( Figure S1 ).
Plasmids encoding the CTX-M-15 ESBL were placed in five groups on the basis of their FAB formula; F2:A2:B2, F2:A1:B2, F22:A1:B20, F31:A4:B10 and F31:A4:B1. This result is in agreement with previously reported characterizations of IncF plasmids carrying the bla CTX-M-15 gene, which are not a homogeneous group of plasmids, as suggested by the observed heterogeneity of restriction patterns, sizes and DNA sequences. 2, 23, 27, 31 Three of the CTX-M-15 encoding plasmids (p162237, p177273 and p45545) from our collection, 23, 27 showing the new F31 allele, carried two copies of the FII replicon (demonstrated by Southern blot hybridization on PstI-restricted plasmid DNA; data not shown), as previously described for the pIP1206 plasmid, 32 and were noted since they produced three C/T heteroduplexes in the raw sequencing data. For these plasmids, FII FW -F D RV PCR (Table 3 ) was used to amplify the intact FII replicon for allele assignation.
The K. pneumoniae strains (17829, 17830, 17834 and 71697) producing CTX-M-15 isolated in Italy in 2008 24 (Table 2) showed the coexistence in the same bacterial cell of two unrelated IncF plasmids. These strains carried a K5:A2:B2 plasmid and the F2:A2:B2 plasmid, the latter encoding CTX-M-15. 24 These IncF plasmids clearly showed a compatible phenotype within the same bacterial cell. The F2:A2:B2 plasmid was a derivative of the R100 plasmid and was similar to plasmid pEK516, previously Villa et al.
identified in the ST131 epidemic E. coli clone from the UK (EU935738), and to pC15-1a from E. coli CTX-M-15 producers, which caused a large outbreak in Canada (AY458016). 21, 33 Plasmids p48165T, p169967 and p177243 from E. coli from Italy and the UK 23, 27 also showed this formula, suggesting that the R100 derivative carrying CTX-M-15 has spread worldwide and is probably one of the most frequent bla CTX-M-15 -carrying plasmids circulating among Enterobacteriaceae. The example of the bla CTX-M-15 plasmids showing the F2:A2:B2 formula demonstrated that the same scaffold can be identified in the fully sequenced plasmids available in GenBank (Table 1 ) and in the clinical strains under study ( Table 2 ). The K5:A2:B2 plasmid is probably a Klebsiella virulence plasmid whose function is still unknown, but can easily be recognized in the different strains of our K. pneumoniae collection, showing the novel K5 allele (Table 2 and Figure S1 ).
Four IncF plasmids in our collection, pZM3, IncFI/97, TP160 and TP181, were representative of IncFIme (me, Middle East) plasmids, which contributed to the epidemic spread of S. enterica serotype Wien, causing protracted outbreaks in Europe, the Middle East and North Africa during the early 1970s. 28 All of them were assigned the formula F1:A1:B1, the same as that of pRSB107 (Table 1) . These plasmids were previously demonstrated to maintain very well conserved plasmid scaffolds for 25 years, also evolving by the acquisition of different resistance determinants, 28 and the RST results confirmed their phylogenetic relatedness. Interestingly, a careful analysis of the repA replicase gene of the FII replicon of these plasmids revealed that a complete Tn3 transposon, carrying the bla TEM-1 gene, interrupted the repA gene of pZM3 at 535 bp from the ATG codon, while the insertion of an IS26 element caused a deletion of the repA gene of plasmid IncFI/97 at position 374 from the ATG codon (accession numbers HM769901 and HM769900, respectively). The insertion of mobile elements within the FII replicon did not impair plasmid replication, because of the presence of the FIA and FIB replicons, which assured the replication of these plasmids. These results highlight the role played by the multi-replicon status in the versatility of IncF plasmids, whose complex structure sustained their maintenance also when mobile elements impaired the functionality of some crucial replication determinants.
The discriminatory power of RST seems sufficient to discern unrelated plasmids, but similar plasmid scaffolds can also be recognized. Further examples of conserved plasmids that can be recognized by RST are represented by: (i) the F18:A2:B1 pAPEC-1 (CP000836) and pVM01 (EU330199) plasmids identified in APEC strains isolated in the USA and Australia, respectively; (ii) the five F23:A2:B3 plasmids from different EHEC strains; (iii) the F29:A2:B10 ColIa plasmids identified in uropathogenic E. coli (UPEC) and extraintestinal pathogenic E. coli (ExPEC) strains; and (iv) the various Shigella, Salmonella, Klebsiella and Yersinia virulence plasmids that can be easily detected and discriminated by their FAB formulae (Table 1) .
Nine prototypic plasmids of our collection were analysed by PstI-RFLP (Figure 3) . RFLP analysis showed a great variability of restriction patterns with a discriminatory power comparable to that of the RST method. However, RFLP plasmid patterns cannot be compared easily among different laboratories, while sequence-based typing methods may support inter-laboratory exchanges for many different epidemiological purposes, including the detection of the spread of a common plasmid in different strains from different countries.
Conclusions
The IncF plasmid family is clearly playing a major role in the dissemination of antimicrobial resistance in Enterobacteriaceae. Of 1224 plasmids successfully typed by PBRT, carrying ESBL or plasmid-mediated quinolone or aminoglycoside resistance genes, 331 were assigned to the IncF group (27%), demonstrating that the members of this plasmid family are prevalent in clinical, resistant isolates of Enterobacteriaceae.
11 Such prevalence cannot permit the recognition of similar plasmids simply on the basis of assignation to the IncF family. A further discrimination method is required to identify related plasmid scaffolds from IncF-unrelated plasmids. Furthermore, the simultaneous presence of more than one plasmid of this family, showing compatible phenotypes within the same bacterial cell, further complicates the interpretation of plasmid typing and content in the studied strains. When multiple IncF plasmids are present in the same cell, the application of this typing scheme should be performed on both donor and recipient strains, obtained by mating or transformation, to correctly assign the FAB formula to each single plasmid scaffold. RST may represent a subtyping scheme that is easier to apply than RFLP analysis, as it has already been described for multilocus sequence typing of plasmids belonging to the IncI1, IncHI2 and IncHI1 families. 34 -36 This typing scheme can be used to facilitate inter-laboratory comparative studies on IncF plasmids, to identify similar plasmids from bacteria from different sources and countries and to support molecular epidemiological surveillance of antimicrobial resistance, particulary in relation to IncF plasmids associated with the spread of both virulence and resistance determinants.
